ABCL
Abcellera Biologics Inc
13.80$
+0.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 40.4% | 23.2% | 9.7% | 2,106.4% | 57.1% | -115.4% | -376.5% | -174.8% | |
| 10.4% | 15.9% | 2.3% | 148.6% | 6.8% | 81.2% | 336.4% | 29.5% | |
| 7.0% | 7.7% | 3.6% | 263.9% | 10.2% | 168.8% | 234.4% | 74.3% | |
| 4.8% | 9.3% | 6.5% | 277.3% | 11.5% | – | – | – | |
| 21.6% | 17.0% | -50.1% | 358.9% | 6.1% | 34.8% | -89.6% | -94.1% | |
| 60.1% | 34.4% | 6.3% | 503.4% | 15.0% | 203.8% | 271.9% | 56.9% | |
| -60.1% | -49.8% | -51.4% | -2,861.4% | -72.6% | -581.5% | 421.1% | 116.8% | |
| – | 0.1% | – | – | – | – | – | – | |
| – | -0.1% | 0.0% | -0.1% | – | – | – | – | |
| 22.4% | 1.6% | 36.5% | -8.2% | -0.1% | 30.5% | – | – | |
| 138.0% | 1.7% | 293.2% | -33.5% | -0.3% | 27.2% | 44.3% | 18.7% | |
| 118.3% | -24.9% | 251.6% | -800.7% | -17.8% | -668.1% | 79.8% | -37.8% | |
| -19.7% | -11.2% | 3.4% | 1,603.0% | 42.2% | -319.2% | -648.4% | -231.7% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.